Most top-selling liver supplements on Amazon lack strong scientific evidence for safety or efficacy, with many relying on limited research.

HealthDay News — Nebraska is the first state to get federal approval to ban the purchase of soda and energy drinks under the Supplemental Nutrition Assistance Program (SNAP), also known as food stamps ...

Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.

The average annual national percentage change in mortality from hepatocellular carcinoma from 2005 to 2023 was higher for rural vs urban residents.

China has promised to give $500 million to WHO over the next 5 years, positioning itself to become the group’s top donor.

US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025.

Metabolic dysfunction-associated steatotic liver disease in pregnant women is a risk factor for preterm birth.

The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara ...

GLP-1 RA treatment was linked to 8 fewer AHI events per hour among individuals with elevated body weight and moderate to severe OSA who did not have diabetes. Glucagon-like peptide-1 receptor agonists ...

The FDA is implementing an enhanced review process for food chemicals currently available on the US market, with a particular focus on those that have raised consumer concerns. HealthDay News — The ...

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.